Latest Articles
- The electronic medical record: Learning to swim
Skepticism and vigilance are warranted, but so is optimism.
- Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes
Powerful antithrombotic and antiplatelet drugs and percutaneous interventions pose risks of bleeding. Fortunately, the risk can be managed.
- LVH and hypertension: Is treating the pressure not enough?
I am not sure the weight of current evidence supports routinely screening hypertensive patients for left ventricular hypertrophy using echocardiography, but the concept warrants consideration and study.
- Should patients with mild asthma use inhaled steroids?
Yes—but only if we consider the severity of the asthma, the goals of therapy, and the benefits and risks.
Left ventricular hypertrophy: An overlooked cardiovascular risk factorAntihypertensive treatment that causes left ventricular hypertrophy to regress also decreases rates of cardiovascular morbidity and death, independently of how much the blood pressure is lowered.